RxDoctor Payments Data

Abigail Moore

Optometrist · Eau Claire, WINPI 1316397615

Payments from drug & device makers

$584in general payments, 2019–2025

Across 25 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$118
  • ABB Con-cise Optical Group LLC$116
  • AbbVie$76
  • Bausch & Lomb Americas Inc.$71
  • Coopervision Inc.$63
  • Oyster Point Pharma, Inc.$57
  • plus $83 from 4 others

What the payments were for

  • Food & beverage$584100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$584 in reported general payments places this provider in the 50th percentile of 867 optometrist providers in Wisconsin.

See all optometrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$111,674
Medicare patients
688
Services billed
1,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine36$39,403
Cyclosporine12$9,294
Latanoprost401$3,024
Prednisolone Acetate36$1,498
Timolol Maleate118$1,259
Brimonidine Tartrate28$1,009
Fluorometholone13$863
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha36$469
Ketorolac Tromethamine18$412
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat18$249
ErythromycinErythromycin Base16$181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis$76$39,40336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 867 optometrist providers in Wisconsin.

Other optometrist in Eau Claire

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →